Rymbai, M., & Borah, V. V. (2026). Impact of the revised CLSI M100 (36th edition, 2026) minimum inhibitory concentration breakpoints on antimicrobial susceptibility interpretation and multidrug-resistance classification of clinical Pseudomonas aeruginosa isolates: a retrospective study. International Journal of Basic & Clinical Pharmacology, 15(5), 1002–1009. https://doi.org/10.18203/2319-2003.ijbcp20262873